Calendula officinalis for Health & Longevity - Quick Reference Sheet
evipedia.aidev
← Back

Calendula officinalis for Health & Longevity

Created on 08/09/2026 – Quick Reference based on Evidence Review created using AI4L / Grok 4 – Audit

Calendula flower extract is mainly a topical option for minor skin irritation and wound support. Medium-strength evidence supports faster healing of some acute wounds and less pain after birth-related surgical cuts; radiation-skin protection results are mixed. Main risks are daisy-family contact allergy and local irritation. Not a whole-body longevity treatment. (Full Review)

Protocol

Form
Topical ointment or oily extract
Flower-based ointment, cream, or oily extract as studied for skin support
Application
2–4× daily
To clean minor wounds, irritated skin, or radiation fields; at least twice daily in radiation-skin protocols
Concentration / course
~2%–10% ointment
2%–20% tincture as studied for wound care; continue until epithelialization or throughout radiotherapy
Time to effect
Radiation skin support
Across multi-week course
Dermatitis prevention signal tracked over a full radiotherapy course
Acute wound coverage
About 1–2 weeks
Measurable surface-healing differences in acute-wound trials
Local soothing
Hours to a few days
Symptom relief at irritated or wounded skin

Benefits

Contraindications
  • Asteraceae allergy (ragweed, chrysanthemums, daisies, chamomile, echinacea, arnica; absolute, all routes)
  • Pregnancy and lactation for oral calendula (traditional caution); large-area topical only with clinician input
  • Extensive partial- or full-thickness burns without specialist supervision
  • Deep puncture wounds, animal bites, or signs of systemic infection without medical evaluation
  • Children under labeled monograph ages (often ≥6 years for skin, ≥12 years for mouth/throat products)
    •
Key Interactions
  • Sedating or photosensitizing topicals
  • OTC topicals on the same site (hydrocortisone 1%, benzocaine, hydrogen peroxide, iodine antiseptics)
  • Anticoagulant or antiplatelet oral regimens if using oral extracts (warfarin, apixaban, rivaroxaban, aspirin, clopidogrel)
  • High-potency topical corticosteroids or calcineurin inhibitors (tacrolimus, pimecrolimus)
    •

Risk & Side Effects

  • High: Allergic contact dermatitis
    •
  • Medium: Local irritation or stinging on broken skin
    •
  • Low: Delayed recognition of infection or serious wound pathology
    •
  • Speculative: Systemic effects from high-dose oral use in pregnancy; Theoretical CYP or transporter interactions after chronic high-dose oral extract
    •

Monitoring

Marker Target Why
Clinical dermatitis / wound grade Grade 0–1 preferred during radiotherapy Tracks primary efficacy and escalation need
Wound surface area Progressive ≥10–15%/week reduction when healing Objective healing velocity
Local pain score Downward trend within 48–72 h for minor wounds Patient-centered response
Signs of infection Absent Safety stop rule
Patch-test / allergy history Negative for Compositae when feasible Prevents allergic dermatitis

Cadence: Daily self-inspection during active wound care; at least weekly clinician review for radiation dermatitis; reassess chronic ulcers every 1–2 weeks with surface-area measurement

Qualitative Assessment

  • Reduced stinging, tightness, or itch at the application site
  • Visible epithelial advance from wound edges without heavy crust or odor
  • Ability to complete planned radiotherapy without treatment breaks for skin toxicity
  • Cosmetic skin comfort sufficient for sleep and clothing friction
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.